LISATA THERAPEUTICS, INC. — Director's Dealing 2015

Jun 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2015-06-02

Reporting Person: Preti Robert A (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-02	Stock Option (right to purchase)	$2.26	A	33750	Acquired	2025-06-01	Common Stock, par value $0.001 per share (33750)	Direct

Footnotes

F1: On June 2, 2015 (the "Grant Date"), the Reporting Person was granted an option, under the Company's 2009 Equity Compensation Plan (the "Plan") to purchase 33,750 shares of the Issuer's common stock, $.001 par value, subject to all of the terms and conditions of the Plan. This option vests as follows: as to 25% of the shares on the Grant Date, and the remaining 75% shall vest quarterly over a period of thirty-six months from the Grant Date.